Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares are trading flat. The stock gained premarket on possible continued momentum after the company announced preliminary fourth-quarter and fiscal-year revenues above estimates. Unprecedented Growth: Revenue Soars 55% Year-Over-Year Adaptive…
Continue reading...